Summary
Factors associated with long-term prognosis after ischemic stroke treated with fibrinolytic agents
Gallardo Tur A, García Casares N, De la Cruz Cosme C, Jiménez Parras M, Temboury Ruiz F, Rosell Vergara E, Márquez Martínez M, Fernández O
Affiliation of the authors
UGC Intercentros de Neurociencias, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional de Málaga y Virgen de la Victoria, Málaga, Spain. Departamento de Medicina, Facultad de Medicina, Universidad de Málaga; Centro de Investigaciones Medico Sanitarias (CIMES), Málaga, Spain. UGCI de Cuidados Críticos y Emergencias. Hospital Regional Universitario y Virgen de la Victoria, Málaga, Spain.
DOI
Quote
Gallardo Tur A, García Casares N, De la Cruz Cosme C, Jiménez Parras M, Temboury Ruiz F, Rosell Vergara E, et al. Factors associated with long-term prognosis after ischemic stroke treated with fibrinolytic agents. Emergencias. 2015;27:34-8
Summary
Objective.
Material and methods. The cases of 63 patients with characteristics leading to activation of a stroke code were analyzed retrospectively. The patients received fibrinolytic therapy in a referral hospital for the western district of Malaga, Spain. We recorded the time until start of fibrinolytic therapy, severity according to the National Institute of Health Stroke Scale (NIHSS) at baseline and at 24 hours, and functional outcome at 3 months according to the modified Rankin Scale.
Results.
on the modified Rankin scale and other variables were as follows: NIHSS score at 24 hours, ρ = 0.73; P < .01; NIHSS at baseline, ρ = 0.34; P = .01); age, ρ = 0.41; P = .001); time until start of fibrinolysis, ρ = 0.21; P = .09); change in NIHSS score at 24 hours, ρ = 0.61; P = .001).
Conclusions.